During the past decade, Allergy Clinic of Tulsa conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy Clinic of Tulsa" are "Hereditary Angioedema" (4 trials), "Hereditary Angioedema (HAE)" (1 trials) and "Seasonal Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Allergy Clinic of Tulsa" in a lesser frequency.

Most popular intervention types in "Allergy Clinic of Tulsa" are "Biological" (4 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "C1 esterase inhibitor [human] (C1INH-nf)" (4 trials), "Placebo" (2 trials), "Placebo (saline)" (2 trials), "C1 esterase inhibitor [human] liquid" (1 trials) and "azelastine Hcl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Clinic of Tulsa" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Clinic of Tulsa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Allergy Clinic of Tulsa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Clinic of Tulsa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".